Factors associated with influenza and pneumococcal vaccine uptake among rheumatoid arthritis patients in Denmark invited to participate in a pneumococcal vaccine trial (Immunovax_RA)

被引:41
作者
Nguyen, M. T. T. [1 ,2 ,3 ]
Lindegaard, H. [4 ]
Hendricks, O. [5 ,6 ]
Friis-Moller, N. [1 ]
机构
[1] Odense Univ Hosp, Dept Infect Dis, Sdr Blvd 29,Entrance 18,2nd Floor Penthouse, DK-5000 Odense C, Denmark
[2] Univ Southern Denmark, Inst Clin Res, Odense, Denmark
[3] Odense Univ Hosp, OPEN, Odense Patient Data Explorat Network, Odense, Denmark
[4] Odense Univ Hosp, Dept Rheumatol, Odense, Denmark
[5] King Christian 10th Hosp Rheumat Dis, Dept Rheumatol, Grasten, Denmark
[6] Univ Southern Denmark, Inst Reg Res, Odense, Denmark
关键词
23-VALENT POLYSACCHARIDE VACCINE; CONJUGATE VACCINE; ANTIBODY-RESPONSES; IMMUNOSUPPRESSIVE THERAPY; TNF BLOCKERS; ADULTS; METHOTREXATE; RISK; COVERAGE; DISEASES;
D O I
10.1080/03009742.2016.1242774
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objective: This study investigates predictors of influenza and pneumococcal vaccine coverage among rheumatoid arthritis (RA) patients, and explores possible differences according to type of RA therapy.Method: RA patients from two clinics in the region of Southern Denmark were informed about the survey during scheduled follow-up visits. The questionnaire included questions concerning previous influenza and pneumococcal vaccine uptake, attitudes about vaccination, and socio-demographic factors. Factors associated with recalled vaccine uptake were assessed by multivariate logistic regression.Results: A total of 192 RA patients completed the survey, 134 (70%) of whom were women and 90 (47%) were aged 65years. Sixty-seven patients (35%) received conventional disease-modifying anti-rheumatic drugs (cDMARDs) and 125 (65%) combination therapy with biological disease-modifying anti-rheumatic drugs (bDMARDs). Self-reported uptake of vaccination against seasonal influenza ever was 59% overall; 57% among patients receiving cDMARDs and 61% in patients receiving bDMARDs. Self-reported vaccine uptake against pneumococcal diseases was only 6% overall. Older age, educational level, and information and recommendation by a specialist or general physician were positively associated with influenza vaccine uptake, while there was no significant difference in vaccine uptake according to RA treatment type. Reasons for not being vaccinated included fear of adverse effects, lack of information and recommendation, and perception of good health.Conclusion: We observed a low prevalence of influenza and in particular of pneumococcal vaccinations among RA patients receiving immunosuppressive drugs, with no difference in coverage according to type of RA therapy. More population-specific evidence to support recommendations is required to increase awareness among patients and physicians.
引用
收藏
页码:446 / 453
页数:8
相关论文
共 57 条
[1]   Pneumococcal and influenza vaccination rates in patients treated with corticosteroids and/or immunosuppressive therapies for systemic autoimmune diseases: A cross-sectional study [J].
Assala, Manal ;
Groh, Matthieu ;
Blanche, Philippe ;
Vinter, Christine ;
Cohen, Pascal ;
Le Guern, Veronique ;
Puechal, Xavier ;
Mouthon, Luc ;
Le Jeunne, Claire ;
Launay, Odile ;
Kerneis, Solen .
JOINT BONE SPINE, 2017, 84 (03) :365-366
[2]   TNF blockers show distinct patterns of immune response to the pandemic influenza A H1N1 vaccine in inflammatory arthritis patients [J].
Avelino Franca, Ivan Leonardo ;
Medeiros Ribeiro, Ana Cristina ;
Aikawa, Nadia Emi ;
Schain Saad, Carla Goncalves ;
Bertacine Moraes, Julio Cesar ;
Goldstein-Schainberg, Claudia ;
Magalhaes Laurindo, Ieda Maria ;
Precioso, Alexander Roberto ;
Ishida, Maria Akiko ;
Christovam Sartori, Ana Marli ;
Silva, Clovis Artur ;
Bonfa, Eloisa .
RHEUMATOLOGY, 2012, 51 (11) :2091-2098
[3]   Vaccination of the immunosuppressed adult patient with rheumatologic disease [J].
Avery, RK .
RHEUMATIC DISEASE CLINICS OF NORTH AMERICA, 1999, 25 (03) :567-+
[4]   Influenza Vaccination for Immunocompromised Patients: Systematic Review and Meta-analysis by Etiology [J].
Beck, Charles R. ;
McKenzie, Bruce C. ;
Hashim, Ahmed B. ;
Harris, Rebecca C. ;
Nguyen-Van-Tam, Jonathan S. .
JOURNAL OF INFECTIOUS DISEASES, 2012, 206 (08) :1250-1259
[5]  
Bennett Nancy M., 2012, Morbidity and Mortality Weekly Report, V61, P816
[6]   Immunization Responses in Rheumatoid Arthritis Patients Treated With Rituximab Results From a Controlled Clinical Trial [J].
Bingham, Clifton O., III ;
Looney, R. John ;
Deodhar, Atul ;
Halsey, Neal ;
Greenwald, Maria ;
Codding, Christine ;
Trzaskoma, Benjamin ;
Martin, Flavius ;
Agarwal, Sunil ;
Kelman, Ariella .
ARTHRITIS AND RHEUMATISM, 2010, 62 (01) :64-74
[7]   Rheumatoid arthritis and the incidence of influenza and influenza-related complications: a retrospective cohort study [J].
Blumentals, William A. ;
Arreglado, Anna ;
Napalkov, Pavel ;
Toovey, Stephen .
BMC MUSCULOSKELETAL DISORDERS, 2012, 13
[8]   Polysaccharide Conjugate Vaccine against Pneumococcal Pneumonia in Adults [J].
Bonten, M. J. M. ;
Huijts, S. M. ;
Bolkenbaas, M. ;
Webber, C. ;
Patterson, S. ;
Gault, S. ;
van Werkhoven, C. H. ;
van Deursen, A. M. M. ;
Sanders, E. A. M. ;
Verheij, T. J. M. ;
Patton, M. ;
McDonough, A. ;
Moradoghli-Haftvani, A. ;
Smith, H. ;
Mellelieu, T. ;
Pride, M. W. ;
Crowther, G. ;
Schmoele-Thoma, B. ;
Scott, D. A. ;
Jansen, K. U. ;
Lobatto, R. ;
Oosterman, B. ;
Visser, N. ;
Caspers, E. ;
Smorenburg, A. ;
Emini, E. A. ;
Gruber, W. C. ;
Grobbee, D. E. .
NEW ENGLAND JOURNAL OF MEDICINE, 2015, 372 (12) :1114-1125
[9]   Influenza and pneumococcal vaccine coverage in 584 patients taking biological therapy for chronic inflammatory joint: A retrospective study [J].
Brocq, Olivier ;
Acquacalda, Emilie ;
Berthier, Frederic ;
Albert, Christine ;
Bolla, Gilles ;
Millasseau, Elodie ;
Destombe, Claire ;
Azulay, Johanna ;
Asquier, Caroline ;
Florent, Amelie ;
Le Seaux, Sylvie ;
Euller-Ziegler, Liana .
JOINT BONE SPINE, 2016, 83 (02) :155-159
[10]   Immunogenicity, Safety, and Tolerability of 13-Valent Pneumococcal Conjugate Vaccine Followed by 23-Valent Pneumococcal Polysaccharide Vaccine in Recipients of Allogeneic Hematopoietic Stem Cell Transplant Aged ≥2 Years: An Open-Label Study [J].
Cordonnier, Catherine ;
Ljungman, Per ;
Juergens, Christine ;
Maertens, Johan ;
Selleslag, Dominik ;
Sundaraiyer, Vani ;
Giardina, Peter C. ;
Clarke, Keri ;
Gruber, William C. ;
Scott, Daniel A. ;
Schmoele-Thoma, Beate .
CLINICAL INFECTIOUS DISEASES, 2015, 61 (03) :313-323